22. もやもや病 Moyamoya disease Clinical trials / Disease details


臨床試験数 : 14 薬物数 : 21 - (DrugBank : 14) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 44

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03882060
(ClinicalTrials.gov)
April 8, 201912/3/2019Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya PatientsThe Effect of Recombinant Human Erythropoietin on the Postoperative Neurologic Outcome in Pediatric Moyamoya Disease Patients - A Double Blind Randomized Controlled TrialMoyamoya Disease;Pediatrics;Cerebrovascular DisordersDrug: erythropoietin;Drug: Normal salineSeoul National University HospitalNULLActive, not recruitingN/A18 YearsAll60N/AKorea, Republic of
2NCT03162588
(ClinicalTrials.gov)
May 1, 201018/5/2017Multiple Burrhole Therapy With Erythropoietin for Unstable MoyamoyaFeasibility Study of Multiple Burrhole Therapy Combined With Intravenous Erythropoietin Pretreatment for Unstable MoyamoyaIschemic Attack;Ischemic Stroke;Moyamoya Disease;Burr Hole;AngiogenesisDrug: erythropoietinAjou University School of MedicineNULLCompleted16 YearsN/AAll37Phase 1/Phase 2Korea, Republic of